[CH2:1]1[C@@H:6]([NH2:7])[C@H:5]([O:8][C@H:9]2[O:14][C@H:13]([CH2:15][OH:16])[C@@H:12]([OH:17])[C@H:11]([NH2:18])[C@H:10]2[OH:19])[C@@H:4]([OH:20])[C@H:3]([O:21][C@H:22]2[O:27][C@H:26]([CH2:28][NH2:29])[C@@H:25]([OH:30])[CH2:24][C@H:23]2[NH2:31])[C@H:2]1[NH2:32].OS(O)(=O)=O>O>[CH2:1]1[C@@H:6]([NH2:7])[C@H:5]([O:8][C@H:9]2[O:14][C@H:13]([CH2:15][OH:16])[C@@H:12]([OH:17])[C@H:11]([NH2:18])[C@H:10]2[OH:19])[C@@H:4]([OH:20])[C@H:3]([O:21][C@H:22]2[O:27][C@H:26]([CH2:28][NH2:29])[C@@H:25]([OH:30])[CH2:24][C@H:23]2[NH2:31])[C@H:2]1[NH2:32]Foam wound materials containing tobramycin sulfate were prepared as shown in Example 1. Once the materials were placed onto grid supports they were maintained at room temperature and covered with a foil wrap. Every 12 hours for nine days, 5 ml of water was applied onto the foam bandage materials and eluent was collected. Two ml samples containing SDMC-entrapped tobramycin were assayed for tobramycin antibiotic activity using standard antimicrobial assays. The results are shown in Table IX.